Financials
- Market Capitalization 1.49 B
- Employee 140
- Founded 2011
- CEO N/A
- Website www.absci.com
- Headquarter Washington, United States
- FIGI BBG011N54CJ8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-14.67
ratio cours/chiffre d'affaires
1 072.51
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2179 | NVAX Novavax, Inc. - Common Stock | 9.64 USD | +4.10% | +12.22% | +30.98% | +30.45% | 1.59 B USD | ||
| 2184 | INVA Innoviva, Inc. - Common Stock | 20.97 USD | +0.05% | -0.38% | 0.00% | +17.68% | 1.51 B USD | ||
| 2195 | TYRA Tyra Biosciences, Inc. - Common Stock | 24.38 USD | -2.25% | -6.55% | -21.51% | +70.01% | 1.45 B USD | ||
| 2198 | AVBP ArriVent BioPharma, Inc. - Common Stock | 29.42 USD | -2.49% | +4.47% | -0.24% | +52.04% | 1.45 B USD |